Alternative splice variants of the human PKR protein kinase possessing different 5'-untranslated regions: Expression in untreated and interferon- treated cells and translational activity

Virology

Volumn 264, Issue 1, 1999, Pages 106-114

  Kawakubo, Ken ^a   Kuhen, Kelli L ^a   Vessey, Jill W ^a   George, Cyril X ^a   Samuel, Charles E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED RNA; INTERFERON; PROTEIN KINASE;

ALTERNATIVE RNA SPLICING; ANTIVIRAL ACTIVITY; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME INDUCTION; EXON; HUMAN; HUMAN CELL; INTERFERON INDUCTION; MOLECULAR CLONING; PLACENTA; PRIORITY JOURNAL; PROTEIN PROCESSING; RNA TRANSLATION; VIRUS REPLICATION;

EID: 0033544339     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9995     Document Type: Article

References (43)

1. Atwater J. A., Munemitsu S. M., Samuel C. E. Biosynthesis of reovirus-specified polypeptides: Efficiency of expression of cDNAs of the reovirus S1 and S4 genes in transfected animal cells differs at the level of translation. Virology. 159:1987;350-357.
2. Bevilacqua P. C., George C. X., Samuel C. E., Cech T. R. Binding of the protein kinase PKR to RNAs with secondary structure defects: Role of the tandem A-G mismatch and noncontiguous helixes. Biochemistry. 37:1998;6303-6316.
3. Bischoff J. R., Samuel C. E. Mechanism of interferon action: The interferon-induced phosphoprotein P1 possesses a double-stranded RNA-dependent ATP-binding site. J. Biol. Chem. 260:1985;8237-8239.
4. Carpick B. W., Graziano V., Schneider D., Maitra R. K., Lee X., Williams B. R. G. Characterization of the solution complex between the interferon-induced, double-stranded RNA-activated protein kinase and HIV-1 trans-activating region RNA. J. Biol. Chem. 272:1997;9510-9516.
5. Chenchik A., Moqadam F., Siebert P. Marathon cDNA amplification: A new method for cloning full-length cDNAs. Clontech. X:1995;5-8.
6. Clemens M. J., Elia A. The double-stranded RNA-dependent protein kinase PKR: Structure and function. J. Interfer. Cytokine Res. 17:1997;503-524.
7. Chomczynski P., Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-169.
8. Frohman M. A., Dush M. K., Martin G. R. Rapid production of full-length cDNAs from rare transcripts: Amplification using a single gene specific oligonucletide primer. Proc. Natl. Acad. Sci. USA. 85:1988;8998-9002.
9. George C. X., Samuel C. E. Human RNA specific adenosine deaminase ADAR1 transcripts possess alternative exon 1 structures that initiate from different promoters, one constitutively active and the other interferon-inducible. Proc. Natl. Acad. Sci. USA. 96:1999;4621-4626.
10. Hershey J. W. B. Protein phosphorylation controls translation rates. J. Biol. Chem. 264:1989;20823-20826.
11. Katze M. G. Regulation of the interferon-induced PKR: Can viruses cope? Trends Microbiol. 3:1995;75-78.
12. Kawakubo K., Ohyashiki J. H., Ohyashiki K., Tauchi T., Kimura N., Nakazawa S., Toyama K. Hypomethylated status, but not RAG-1, is required for T-cell receptor-β-chain gene rearrangement in acute leukemia cells. Cancer Genet. Cytogenet. 78:1994;40-45.
13. Kharrat A., Macias M. J., Gibson T. J., Nilges M., Pastore A. Structure of the dsRNA binding domain of E. coli RNase III. EMBO J. 14:1995;3572-3584.
14. Kozak M. Regulation of translation in eukaryotic systems. Annu. Rev. Cell Biol. 8:1992;197-225.
15. Kuhen, K. L. 1997, Structural organization and transcriptional regulation of the interferon-inducible, RNA-activated protein kinase Pkr gene. PhD thesis, University of California, Santa Barbara.
16. Kuhen K. L., Samuel C. E. Isolation of the interferon-inducible RNA-dependent protein kinase Pkr promoter and identification of a novel DNA element within the 5′-flanking region of the human, and mouse Pkr genes. Virology. 227:1997;119-130.
17. Kuhen K. L., Shen X., Carlisle E. R., Richardson A. L., Weier H.-U. G., Tanaka H., Samuel C. E. Mechanism of interferon action: Structural organization of the human Pkr gene encoding an interferon-inducible RNA-dependent protein kinase (PKR) and differences from its mouse homolog. Genomics. 36:1996;197-201.
18. Kuhen K. L., Vessey J. W., Samuel C. E. Mechanism of interferon action: Identification of essential positions within the novel 15-base pair KCS element required for transcriptional activation of the RNA-dependent protein kinase Pkr gene. J. Virol. 72:1998;9934-9939.
19. Liu Y., Emeson R. B., Samuel C. E. Serotonin-2C receptor pre-mRNA editing in rat brain and in vitro by splice site variants of the interferon-inducible double-stranded RNA-specific adenosine deaminase ADAR1. J. Biol. Chem. 274:1999;18351-18358.
20. Liu Y., Samuel C. E. Editing of glutamate receptor subunit B pre-mRNA by splice-site variants of interferon-inducible dsRNA-specific adenosine deaminase ADAR1. J. Biol. Chem. 274:1999;5070-5077.
21. Luthman H., Magnusson G. High efficiency polyoma DNA transfection of chloroquine treated cells. Nucleic Acids Res. 11:1983;1295-1308.
22. D values for VAI and TAR RNAs. Virology. 206:1995;511-519.
23. McCormack S. J., Thomis D. C., Samuel C. E. Mechanism of interferon action: Identification of a RNA binding domain within the N-terminal region of the human RNA-dependent P1/eIF-2α protein kinase. Virology. 188:1992;47-56.
24. Meurs E., Chong K., Galabru J., Thomas N. S., Kerr I. M., Williams B. R. G., Hovanessian A. G. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell. 62:1990;379-390.
25. Patel R. C., Stanton P. K., Sen G. C. Specific mutations near the amino terminus of double-stranded RNA-dependent protein kinase (PKR) differentially affect its double-stranded RNA binding and dimerization properties. J. Biol. Chem. 271:1996;25657-25663.
26. Patterson J. B., Samuel C. E. Expression and regulation by interferon of a double-stranded-RNA specific adenosine deaminase from human cells: Evidence for two forms of the deaminase. Mol. Cell. Biol. 15:1995;5376-5388.
27. Romano P. R., Garcia-Barrio M. T., Zhang X., Wang Q., Taylor D. R., Zhang F., Herring C., Mathews M. B., Qin J., Hinnenbush A. G. Autophosphorylation in the activation loop is required for full kinase activity in vivo of human and yeast eukaryotic initiation factor 2α kinases PKR and GCN2. Mol. Cell Biol. 18:1998;2282-2297.
28. Rueter S., Dawson T. R., Emeson R. B. Regulation of alternative splicing by RNA editing. Nature. 399:1999;75-80.
29. Saiki R. K., Scharf S., Faloona F., Mullis K. B., Horn G. T., Erlich H. A., Arnheim N. Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science. 230:1985;1350-1354.
30. Sambrook J., Fritsch E. F., Maniatis G. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
31. Samuel C. E. Mechanism of interferon action: Phosphorylation of protein synthesis initiation factor eIF-2 in interferon-treated human cells by a ribosome-associated protein kinase possessing site-specificity similar to hemin-regulated rabbit reticulocyte kinase. Proc. Natl. Acad. Sci. USA. 76:1979;600-604.
32. Samuel C. E. Antiviral actions of interferon: Interferon-regulated cellular proteins and their surprisingly selective antiviral activities. Virology. 183:1991;1-11.
33. Samuel C. E. The eIF-2α protein kinases, regulators of translation in eukaryotes from yeasts to humans. J. Biol. Chem. 268:1993;7603-7606.
34. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA. 74:1977;5463-5467.
35. Scadden A. D., Smith C. W. A ribonuclease specific for inosine-containing RNA: A potential role in antiviral defence? EMBO J. 16:1997;2140-2149.
36. Sen G. C., Lengyel P. The interferon system: A bird's eye view of its biochemistry. J. Biol. Chem. 267:1992;5017-5020.
37. Stark G. R., Kerr I. M., Williams B. R. G., Silverman R. H., Schrieber R. D. How cells respond to interferons. Annu. Rev. Biochem. 67:1998;227-264.
38. Tanaka H., Samuel C. E. Mechanism of interferon action. Structure of the mouse PKR gene encoding the interferon-inducible RNA-dependent protein kinase. Proc. Natl. Acad. Sci. USA. 91:1994;7995-7999.
39. Thomis D. C., Doohan J. P., Samuel C. E. Mechanism of interferon action: cDNA structure, expression and regulation of the interferon-induced, RNA-dependent Pl/eIF-2α protein kinase from human cells. Virology. 188:1992;33-46.
40. Thomis D. C., Samuel C. E. Mechanism of interferon action: Evidence for intermolecular autophosphorylation and autoactivation of the interferon-induced, RNA-dependent protein kinase PKR. J. Virol. 67:1993;7695-7700.
41. White B. A., Bancroft F. C. Cytoplasmic dot hybridization: Simple analysis of relative mRNA levels in multiple small cell or tissue samples. J. Biol. Chem. 257:1982;8569-8572.
42. Xu Z., Williams B. R. G. Genomic features of human PKR: Alternative splicing and a polymorphic CGG repeat in the 5′-untranslated region. J. Interfer. Cytokine Res. 18:1998;609-616.
43. Zhou A., Hassel B. A., Silverman R. H. Expression cloning of 2-5A-dependent RNAase: A uniquely regulated mediator of interferon action. Cell. 72:1993;753-765.